Change in the number of Meda AB shares As of 31 January 2008, the number of shares in Meda AB is 259,065,485, which constitutes a 2,386,134 increase in shares compared with the previous month. The increase is due to newly issued shares via redemption of warrants, exercised primarily by Stena Sessan Rederi AB. After the warrants redemption, the Stena Sessan Group's 1) shareholding rose to 67,151,652, which is comparable to 25.9% of Meda's share capital and votes. An additional 905,432 new shares can be subscribed for via redemption of warrants. If fully exercised, the dilution effect of Meda's share capital and votes is 0.03%. The warrant program ends on 26 February 2008. 1) Stena Sessan Rederi AB and Stena Jutlandica AB For more information, please contact: Anders Larnholt, Investor Relations, tel. +46 709 458 878 MEDA AB (publ) is an international specialty pharma company that concentrates on marketing and market-adapted product development. Acquisitions and long-term partnerships are fundamental factors that drive the company's strategy. Meda is represented with own organisations in 26 countries and with more than 1 500 employees within marketing and sales. Meda's products are sold in approximately 120 countries world-wide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit www.meda.se.